Authors:
YAN G
AKIYAMA A
SPACCIAPOLI P
PAQUETTE D
WILLIAMS R
LAWRENCE H
FRIDEN PM
Citation: G. Yan et al., SALIVARY METABOLISM OF HISTATIN PEPTIDE P-113 - IN-VITRO AND PHASE-I CLINICAL-RESULTS, Journal of dental research, 77, 1998, pp. 726-726
Authors:
PAQUETTE DW
WATERS GS
STEFANIDOU VL
LAWRENCE HP
FRIDEN PM
OCONNOR SM
SPERATI JD
OPPENHEIM FG
HUTCHENS LH
WILLIAMS RC
Citation: Dw. Paquette et al., INHIBITION OF EXPERIMENTAL GINGIVITIS IN BEAGLE DOGS WITH TOPICAL SALIVARY HISTATINS, Journal of clinical periodontology, 24(4), 1997, pp. 216-222
Citation: Pm. Friden, UTILIZATION OF AN ENDOGENOUS CELLULAR-TRANSPORT SYSTEM FOR THE DELIVERY OF THERAPEUTICS ACROSS THE BLOOD-BRAIN-BARRIER, Journal of controlled release, 46(1-2), 1997, pp. 117-128
Authors:
SPACCIAPOLI P
TRAN L
ROBERTS FD
FRIDEN PM
Citation: P. Spacciapoli et al., CHARACTERIZATION OF THE ANTIMICROBIAL SPECTRUM OF THE HISTATIN PEPTIDE P-113, Journal of dental research, 76, 1997, pp. 2736-2736
Authors:
FRIDEN PM
OLSON TS
OBAR R
WALUS LR
PUTNEY SD
Citation: Pm. Friden et al., CHARACTERIZATION, RECEPTOR MAPPING AND BLOOD-BRAIN-BARRIER TRANSCYTOSIS OF ANTIBODIES TO THE HUMAN TRANSFERRIN RECEPTOR, The Journal of pharmacology and experimental therapeutics, 278(3), 1996, pp. 1491-1498
Authors:
WALUS LR
PARDRIDGE WM
STARZYK RM
FRIDEN PM
Citation: Lr. Walus et al., ENHANCED UPTAKE OF RSCD4 ACROSS THE RODENT AND PRIMATE BLOOD-BRAIN-BARRIER AFTER CONJUGATION TO ANTITRANSFERRIN RECEPTOR ANTIBODIES, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 1067-1075
Authors:
BROADWELL RD
BAKERCAIRNS BJ
FRIDEN PM
OLIVER C
VILLEGAS JC
Citation: Rd. Broadwell et al., TRANSCYTOSIS OF PROTEIN THROUGH THE MAMMALIAN CEREBRAL EPITHELIUM ANDENDOTHELIUM .3. RECEPTOR-MEDIATED TRANSCYTOSIS THROUGH THE BLOOD-BRAIN-BARRIER OF BLOOD-BORNE TRANSFERRIN AND ANTIBODY AGAINST THE TRANSFERRIN RECEPTOR, Experimental neurology, 142(1), 1996, pp. 47-65
Authors:
CHARLES V
MUFSON EJ
FRIDEN PM
BARTUS RT
KORDOWER JH
Citation: V. Charles et al., ATROPHY OF CHOLINERGIC BASAL FOREBRAIN NEURONS FOLLOWING EXCITOTOXIC CORTICAL-LESIONS IS REVERSED BY INTRAVENOUS ADMINISTRATION OF AN NGF CONJUGATE, Brain research, 728(2), 1996, pp. 193-203
Authors:
BACKMAN C
BIDDLE PT
EBENDAL T
FRIDEN PM
GERHARDT GA
HENRY MA
MACKERLOVA L
SODERSTROM S
STROMBERG I
WALUS L
HOFFER BJ
GRANHOLM AC
Citation: C. Backman et al., EFFECTS OF TRANSFERRIN RECEPTOR ANTIBODY-NGF CONJUGATE ON YOUNG AND AGED SEPTAL TRANSPLANTS IN OCULO, Experimental neurology, 132(1), 1995, pp. 1-15
Authors:
KORDOWER JH
CHARLES V
BAYER R
BARTUS RT
PUTNEY S
WALUS LR
FRIDEN PM
Citation: Jh. Kordower et al., INTRAVENOUS ADMINISTRATION OF A TRANSFERRIN RECEPTOR ANTIBODY NERVE GROWTH-FACTOR CONJUGATE PREVENTS THE DEGENERATION OF CHOLINERGIC STRIATAL NEURONS IN A MODEL OF HUNTINGTON DISEASE, Proceedings of the National Academy of Sciences of the United Statesof America, 91(19), 1994, pp. 9077-9080
Authors:
GRANHOLM AC
BACKMAN C
BLOOM F
EBENDAL T
GERHARDT GA
HOFFER B
MACKERLOVA L
OLSON L
SODERSTROM S
WALUS LR
FRIDEN PM
Citation: Ac. Granholm et al., NGF AND ANTITRANSFERRIN RECEPTOR ANTIBODY CONJUGATE - SHORT AND LONG-TERM EFFECTS ON SURVIVAL OF CHOLINERGIC NEURONS IN INTRAOCULAR SEPTAL TRANSPLANTS, The Journal of pharmacology and experimental therapeutics, 268(1), 1994, pp. 448-459